Purchase Order N0025920P0137
Award Date 2/18/20
Potential Completion Date 10/15/20
Potential Value $128K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Emeryville, CA 94608, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a $2.4 million firm fixed-price purchase order to Grifols Diagnostic Solutions Inc., the original equipment manufacturer and sole source provider, for annual dropshipment of FDA-approved Procleix reagents to support the United States Naval Hospital Okinawa in Japan. The contract, which extends through July 2, 2029, covers three specific test assays for the Procleix Panther nucleic acid testing analyzer: the Ultrio Elite assay, West Nile Virus assay, and...
- Grifols Diagnostic Solutions Inc., a global healthcare company, was awarded a firm-fixed-price purchase order contract worth $154,840.00 by the Department of the Navy Bureau of Medicine and Surgery. The contract is for the supply of Panther Analyzer System reagents and assays, including the Ultrio Elite Test Kit (1,000 tests), West Nile Virus Test Kit (5,000 tests), and Procleix Zika Kit (1,000 tests). These critical medical laboratory supplies are used for the detection of HIV RNA, HCV RNA, HBV...
- This is a firm-fixed-price purchase order contract awarded by the Defense Health Agency to Grifols Diagnostic Solutions Inc., a foreign-owned for-profit subsidiary of the global healthcare company Grifols. The contract is for the provision of 1,000 ULTRIO ELITE test kits to support donor screening at the USNHO PACOM Armed Services Blood Bank Center. The contract has a ceiling value of $2,181,820.00 and a period of performance through July 15, 2024. This requirement was not set aside for any...
- This firm-fixed price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Grifols Diagnostic Solutions Inc., a global healthcare company that provides plasma-derived medicines, transfusion medicine, reagents, equipment, and testing services. The $133,060 contract is for the procurement of 1,000 PROCLEIX ULTRIO ELITE and 5,000 PROCLEIX ZIKA test kits in support of the COVID-19 national interest action. Grifols has extensive experience providing critical...
- This is a firm-fixed-price purchase order award by the Defense Health Agency to Grifols Diagnostic Solutions Inc., a foreign-owned for-profit company, for $600,000.00. The contract is for preventive maintenance and telephone support services for Grifols' Procleix Panther analyzer systems used by the Navy for nucleic acid testing of blood products. The award resulted from a sole-source requirement posted by the Naval Medical Logistics Command. The contract has a period of performance through...
- This contract was awarded by the Department of the Navy Bureau of Medicine and Surgery to Grifols Diagnostic Solutions Inc., a foreign-owned for-profit organization, for the purchase of a PROCLEIX PANTHER BLOOD ANALYZER. The contract is for a firm-fixed price of $237,600.00 and does not have a set-aside designation. The contract requires the delivery of the analyzer, including installation, validation, and initial on-site training, as well as consumables and reagents for HIV, HBV, and HCV...
- This is a sole-source, firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Grifols Diagnostic Solutions Inc., a foreign-owned for-profit subsidiary of the global healthcare company Grifols. The $600,000.00 contract is for annual preventive maintenance services on the Procleix Panther Nucleic Acid Test System located at the United States Naval Hospital Okinawa in Japan. The contract, which has a period of performance from August 24, 2025 to August 23, 2030, was awarded...
- This is a firm-fixed price purchase order contract awarded by the Bureau of Medicine and Surgery, a component of the Department of Defense, to Grifols Diagnostic Solutions Inc., a for-profit global healthcare company. The contract is for the delivery of 3 ULTRIO 1K kits and 1 WNV 5K kit, along with additional reagents and consumables, with a ceiling value of $149,460.78. The contract has a performance period ending on May 4, 2019 and was originally awarded on October 11, 2016. No set-aside...
- This federal contract award is for a LAB TESTING SYSTEM valued at $101,404.80. The contract was awarded by the Defense Health Agency to Grifols Diagnostic Solutions Inc., a global healthcare company that provides plasma-derived medicines, transfusion medicine, reagents, equipment, and testing services. The contract is a firm-fixed price Purchase Order with a completion date of September 30, 2021. This award is not associated with a set-aside program. Grifols supplies critical medical...
- This is a firm-fixed price purchase order awarded by the Department of the Air Force Air Education and Training Command to Grifols Diagnostic Solutions Inc., a global healthcare company, for the delivery of 3 Nucleic Acid Testing Procleix Panther Systems. The total potential value of the contract is $180,000.00, with a completion date of November 28, 2022. This award is not associated with a set-aside program. Grifols has received over $8 million in federal contracts as a prime contractor to...
This is a sole-source contract award to Grifols Diagnostic Solutions Inc., a global healthcare company, by the Department of the Navy Bureau of Medicine and Surgery. The contract is for the procurement of 2 kits of Procleix Babesia (5,000) test kits, which are used with the Procleix Panther systems at the US Naval Hospital Okinawa. The potential value of the contract is $127,600.00, with a firm-fixed price and a completion date of October 15, 2020. This award was made under the authority of FAR 13.106-1(b)(1)(i), as Grifols is the sole proprietor of the Procleix Babesia Assay kits. No set-aside was used for this procurement.
Generated 3/23/24, 4:16 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Notice of Intent to Sole Source | N0025920N0024 | Department of the Navy Naval Supply Systems Command | Solicitation 1/1 | 1/29/20, 4:01 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $127.6k | 2/18/20 |